Catherine M. Szyman, CVP, Critical Care at Edwards Lifesciences Corp (EW), sold 20,000 shares at $106.62 ($2.1M) on 2022-02-18, disclosed to the SEC on 2022-02-18.
Seasonal sale ($2.1M) by CVP, Critical Care — this insider has traded EW in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.74 | 6,900 | $730K | 34.3% |
| 2 | $106.62 | 13,100 | $1.4M | 65.7% |
| Total | $106.32 avg | 20,000 | $2.1M | 100% |
| Filing → |
| EW | SELL | 2023-09-08 | $380K | — | Filing → |
| EW | SELL | 2023-08-09 | $393K | — | Filing → |
| EW | SELL | 2023-07-10 | $453K | — | Filing → |